...
首页> 外文期刊>Journal of pediatric nursing >Harmful medication errors in children: a 5-year analysis of data from the USP's MEDMARX program.
【24h】

Harmful medication errors in children: a 5-year analysis of data from the USP's MEDMARX program.

机译:儿童有害的用药错误:为期5年的USP MEDMARX计划数据分析。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Harmful pediatric medication errors are common in hospitals and health systems. Understanding what products are involved in these errors is important in the prevention of future errors. We used data from a voluntary medication error reporting system (MEDMARX) and identified 816 harmful outcomes involving 242 medications during a 5-year period. Eleven medications accounted for more than one third of reported errors (n = 261 or 34.5%). Wrong dosing and omission errors were common and were associated with therapeutic classes such as opioid analgesics (e.g., morphine and fentanyl), antimicrobial agents (e.g., vancomycin and gentamicin), and antidiabetic agents (e.g., insulin). Older commonly used agents still resulted in a substantial number of harmful pediatric medication errors and should be included in the focus of patient safety activities.
机译:有害的儿科用药错误在医院和卫生系统中很常见。了解哪些产品涉及这些错误对于预防将来的错误很重要。我们使用了自愿药物错误报告系统(MEDMARX)的数据,并在5年期间确定了816种有害结果,涉及242种药物。十一种药物占报告错误的三分之一以上(n = 261或34.5%)。错误的剂量和遗漏错误是常见的,并且与诸如阿片类镇痛药(例如吗啡和芬太尼),抗微生物剂(例如万古霉素和庆大霉素)和抗糖尿病药(例如胰岛素)相关的治疗类别相关。较旧的常用药物仍然会导致大量有害的儿科用药错误,应将其纳入患者安全活动的重点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号